Clinical outcomes after transcatheter aortic valve replacement in South America: A centre‐level systematic review and meta‐analysis of observational data.

Objectives: To estimate in‐hospital and 30‐day outcomes after transcatheter aortic valve replacement (TAVR) in South America through a systematic review and meta‐analysis of observational data. Methods: We comprehensively searched for papers published in peer‐reviewed medical journals and for abstracts presented in medical conferences of the region from 1 September 2008, through 29 June 2020, using predefined criteria. We included single‐centre studies on TAVR populations with ≥10 patients from South America reporting any in‐hospital or 30‐day clinical outcome. Results: Fifty‐five cohorts from seven countries, pooling 3001 patients, were included in a random‐effects meta‐analysis. Self‐expandable prostheses were the most frequently implanted. Pooled estimate of procedure success by VARC2 criteria was 90.0% (95%CI 81.8%‐94.7%; I2 75.0%). The pooled estimate rates of the outcomes were as follow: post‐procedure moderate or severe aortic regurgitation, 9.7% (95%CI 6.0%‐15.4%; I2 65.4%), in‐hospital cardiac tamponade, 4.0% (95%CI 2.5%‐6.6%; I2 0%), in‐hospital stroke, 4.1% (95%CI 2.9%‐5.7%; I2 0%), in‐hospital major vascular complication, 7.8% (95%CI 5.2%‐11.5%; I2 22.3%), in‐hospital permanent pacemaker implantation, 19.4% (95%CI 15.9%‐23.4%; I2 53.8%), in‐hospital mortality, 8.0% (95%CI 6.7%‐9.6%; I2 0%), and 30‐day mortality, 9.7% (95%CI 7.9%‐11.8%; I2 26.4%). Conclusion: As compared with published international registries, the overall results of TAVR in South America seemed underrated. Significant heterogeneity was observed in procedural success, pacemaker requirement, and post‐procedure moderate or severe aortic regurgitation. This study provides a real‐life framework for the analysis of the performance of this technology in the region, intended to be a starting point for quality improvement. [ABSTRACT FROM AUTHOR]